Vancomycin therapy in patients on high-flux HD: a single-centre experience

Phillippa Bailey, Rommel Ravanan

Research output: Contribution to journalArticle (Academic Journal)


Vancomycin is a glycopeptide antibiotic used to treat serious infections with gram-positive bacteria that are resistant to other antibiotics. Patients receiving haemodialysis (HD) via central venous catheters are at an increased risk of gram-positive bacterial infections. Strains of staphylococci and enterococci resistant or only partially sensitive to vancomcyin have developed; therefore, appropriate controlled use of vancomycin is essential.
Original languageEnglish
Pages (from-to)8-9
Number of pages2
JournalBritish Journal of Renal Medicine
Issue number1
Publication statusPublished - May 2014


Dive into the research topics of 'Vancomycin therapy in patients on high-flux HD: a single-centre experience'. Together they form a unique fingerprint.

Cite this